Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
4
×
detroit blog main
4
×
detroit top stories
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
eli lilly
fda
fremanezumab
national
teva pharmaceutical
amgen
calcitonin gene-related peptide
eptinezumab
erenumab
galcanezumab
immunotherapy
migraine
migraine research foundation
What
approval
4
×
drug
fda
new
won
class
companies
developed
migraine
oral
agency
aimmune
allergy
amgen
approved
arguments
awarded
big
bio
biogen’s
biopharmaceutical
candidates
commercialized
competitors
convo
decades
drugs
earlier
failures
friday
gets
head
immunotherapy
late
littered
make
medicines
meeting
nash
neuro
Language
unset
Current search:
approval
×
biotech
×
" clinical trials "
×
" detroit blog main "
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines